<DOC>
	<DOCNO>NCT01677403</DOCNO>
	<brief_summary>This study evaluate efficacy , indication , adverse reaction resistance combine administration nebulized tobramycin compare systemic administration alone patient Bronchiectasis acute exacerbation Bronchiectasis .</brief_summary>
	<brief_title>A Study Access Safety Efficacy Nebulized Tobramycin Patients With Bronchiectasis</brief_title>
	<detailed_description>Bronchiectasis chronic disorder major bronchus bronchiole characterize permanent dilation , microbial infection , persistent inflammatory response release immune mediator microbial toxin lead destruction . The origin bronchiectasis varies , presence microbial infection persistent inflammatory response typical disease . The chronic nature infection associate considerable morbidity provide rationale use aerosolized antibiotic treatment bronchiectasis patient . This study safety efficacy combine administration nebulized tobramycin compare systemic administration alone patient Bronchiectasis acute exacerbation Bronchiectasis . Study subject randomize receive either study drug placebo inhalation via nebulizer . Each subject complete 14 day daily dose . Clinical laboratory parameter , clinical adverse event pulmonary function evaluate study subject order determine qualitative quantitative safety efficacy nebulized tobramycin .</detailed_description>
	<mesh_term>Bronchiectasis</mesh_term>
	<mesh_term>Tobramycin</mesh_term>
	<criteria>1 . Male female study subject ≥18 year age ≤80 year age 2 . Confirmed diagnosis idiopathic bronchiectasis postinfectious bronchiectasis 3 . Confirmation infection P. aeruginosa screen 4 . Are sensitive Tobramycin 5 . Acute exacerbation bronchiectasis 1 . Bronchiectasis due special cause . 2 . Smokers . 3 . Are associated bronchial asthma . 4 . Have serious active medical psychiatric illness . 5 . Are tolerant nebulised tobramycin 6 . FEV1.0 reduce ≥ 15 % inhale tobramycin .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Bronchiectasis</keyword>
	<keyword>Tobramycin</keyword>
	<keyword>nebulised</keyword>
</DOC>